← Back to Conditions

Malignant meningitis

disorder
SNOMED 230156002CUI C0220654

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Clinical Trials

4
Total Trials
4
Recruiting
0
With Results

Recent Trials

Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases

NCT07092202Phase 4Recruiting40 enrolled

Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis

NCT06230055Phase 4Recruiting37 enrolled

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

NCT06058988Phase 2Recruiting30 enrolled

Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma

NCT04661384Phase 1Active Not Recruiting10 enrolled
View all 4 trials on ClinicalTrials.gov

Related Conditions

Non-infective meningitis(parent)
Metastatic malignant neoplasm of meninges(parent)

Quick Facts

SNOMED CT
230156002
UMLS CUI
C0220654
Fully Specified Name
Malignant meningitis (disorder)
Specialists
0
Diagnostic Biomarkers
0
Clinical Trials
4
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.